Brief: SynAct Pharma Q1 Sales SEK 0
27/05/2026 06:31
BRIEF-SynAct Pharma Q1 Sales SEK 0 May 27 (Reuters) - SynAct Pharma Q1 operating expenses SEK 30.558 million.
- Q1 net income SEK -25.487 million
- Q1 adjusted EPS SEK -0.48
- Q1 cash flow from operating activities SEK -32.952 million
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026